Search

Displaying results 6511 - 6520 of 8469 in total
  1. Drug

    Ilginatinib

    go.drugbank.com/drugs/DB12784
    Investigational

    NS-018 has been used in trials studying the treatment of Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, and Post-Essential Thrombocythemia Myelofibrosis.

  2. Drug

    Carboxyamidotriazole

    go.drugbank.com/drugs/DB11960
    Investigational

    Carboxyamidotriazole has been used in trials studying the treatment of Lymphoma, Lung Cancer, Breast Cancer, Kidney Cancer, and Ovarian Cancer, among others.

  3. Drug

    LY-3023414

    go.drugbank.com/drugs/DB12167
    Investigational

    LY3023414 has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, BREAST CANCER, and Advanced Cancer, among others.

  4. Drug

    CUDC-101

    go.drugbank.com/drugs/DB12174
    Investigational

    CUDC-101 has been used in trials studying the treatment of Cancer, Tumors, Liver Cancer, Breast Cancer, and Gastric Cancer, among others.

  5. Drug

    ABT-751

    go.drugbank.com/drugs/DB12254
    Investigational

    ABT-751 has been investigated for the treatment of Lung Cancer, Non-Small Cell Lung Cancer, and Non-Small-Cell Lung Cancer.

  6. Drug

    Samarium

    go.drugbank.com/drugs/DB12403
    Investigational

    Samarium has been used in trials studying the treatment and prevention of Pain, Cancer, Metastasis, Prostate Cancer, and Metastatic Osteosarcoma, among others.

  7. Drug

    9-aminocamptothecin

    go.drugbank.com/drugs/DB12515
    Investigational

    Aminocamptothecin has been used in trials studying the treatment of Lymphoma, Gastric Cancer, Ovarian Cancer, Esophageal Cancer, and Ovarian Neoplasms, among others.

  8. Drug

    Phenethyl Isothiocyanate

    go.drugbank.com/drugs/DB12695
    Investigational

    Phenethyl Isothiocyanate has been used in trials studying the prevention and treatment of Leukemia, Lung Cancer, Tobacco Use Disorder, and Lymphoproliferative Disorders.

  9. Drug

    MG98

    go.drugbank.com/drugs/DB06544
    Experimental

    MG98, a second-generation antisense oligodeoxynucleotide inhibitor of human DNMT1, was investigated in the completed clinical trial NCT00003890 for treating patients with advanced solid tumors.

  10. Drug

    Hycanthone

    go.drugbank.com/drugs/DB14061
    Experimental

    Hycanthone was approved by the FDA in 1975 but is no longer used.